ELEUPHRAT betamethasone 0.05% (as dipropionate) cream tube

Страна: Австралія

мова: англійська

Джерело: Department of Health (Therapeutic Goods Administration)

Активний інгредієнт:

betamethasone dipropionate, Quantity: 0.64 mg/g (Equivalent: betamethasone, Qty 0.5 mg/g)

Доступна з:

ORGANON PHARMA PTY LTD

Фармацевтична форма:

Cream

Склад:

Excipient Ingredients: phosphoric acid; cetostearyl alcohol; white soft paraffin; sodium hydroxide; cetomacrogol 1000; purified water; liquid paraffin; chlorocresol; monobasic sodium phosphate dihydrate

Адміністрація маршрут:

Topical

Терапевтичні свідчення:

Topical treatment of corticosteroid-responsive dermatoses. These include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis. INDICATIONS AS AT 26 August 1992: Eleuphrat is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. These include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis.

Огляд продуктів:

Visual Identification: Smooth white cream.;

Статус Авторизація:

Registered

Дата Авторизація:

1992-09-22

інформаційний буклет

ELEUPHRAT
®
_Betamethasone dipropionate_
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about ELEUPHRAT.
It does not contain all the available
information.
It does not take the place of talking to
your doctor or pharmacist.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you using ELEUPHRAT
against the benefits it is expected to
have for you.
IF YOU HAVE ANY CONCERNS ABOUT THIS
MEDICINE, ASK YOUR DOCTOR OR
PHARMACIST.
KEEP THIS LEAFLET WITH YOUR
MEDICINE.
You may need to read it again.
WHAT ELEUPHRAT IS
USED FOR
The name of your medicine is
ELEUPHRAT. It contains the active
ingredient called betamethasone
dipropionate.
It is a type of cortisone and belongs
to the group of medicines called
corticosteroids. ELEUPHRAT is
classified as a high potency topical
corticosteroid.
There are two forms of
ELEUPHRAT: cream and ointment
ELEUPHRAT is used on the skin to
relieve the redness, swelling, itching
and discomfort of many skin
problems such as:
•
psoriasis (a stubborn skin
disorder with raised, rough,
reddened areas covered with dry,
fine silvery scales)
•
eczema (an often itchy skin
condition with redness, swelling,
oozing of fluid, crusting which
may lead to scaling)
•
other types of dermatitis
Your doctor may have prescribed
ELEUPHRAT for another reason.
ASK YOUR DOCTOR IF YOU HAVE ANY
QUESTIONS ABOUT WHY
ELEUPHRAT HAS BEEN PRESCRIBED
FOR YOU.
This medicine is available only with
a doctor's prescription.
BEFORE YOU USE
ELEUPHRAT
_WHEN YOU MUST NOT USE IT_
DO NOT USE ELEUPHRAT IF YOU
HAVE HAD AN ALLERGIC REACTION (SUCH
AS WHEEZING, RASH OR HIVES) TO:
•
BETAMETHASONE DIPROPIONATE
•
ANY OTHER CORTICOSTEROID
•
ANY OF THE INGREDIENTS LISTED AT
THE END OF THIS LEAFLET
DO NOT USE ELEUPHRAT IF YOU
HAVE:
•
A VIRAL SKIN INFECTION, SUCH AS
COLD SORES, SHINGLES OR CHICKEN
POX
•
A FUNGAL SKIN INFECTION, SUCH AS
THRUSH, TINEA OR RINGWORM
•
TUBERCULOSIS OF THE SKIN
•
ACNE ROSACEA
•
INFLAMMATION AROUND THE
MOUTH
•
SKIN CONDITIONS W

Характеристики продукта

1
AUSTRALIAN PRODUCT INFORMATION
ELEUPHRAT
® (BETAMETHASONE DIPROPIONATE)
CREAM, OINTMENT AND LOTION
1
NAME OF THE MEDICINE
Betamethasone dipropionate
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Betamethasone dipropionate equivalent to betamethasone 0.5 mg/g (0.05%
w/w).
ELEUPHRAT CREAM (0.05% w/w): Each g contains betamethasone
dipropionate equivalent to
betamethasone 0.5 mg.
ELEUPHRAT OINTMENT (0.05% w/w): Each g contains betamethasone
dipropionate equivalent to
betamethasone 0.5 mg.
ELEUPHRAT LOTION (0.05% w/w): Each mL contains betamethasone
dipropionate equivalent to
betamethasone 0.47 mg.
For the full list of excipients, see SECTION 6.1 LIST OF EXCIPIENTS.
3
PHARMACEUTICAL FORM
ELEUPHRAT is supplied as cream. ointment, lotion 0.05% w/w.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
ELEUPHRAT is indicated for the relief of the inflammatory and pruritic
manifestations of
corticosteroid-responsive dermatoses. These include atopic eczema,
infantile eczema, nummular
eczema, contact dermatitis, neurodermatitis, anogenital and senile
pruritus, lichen planus, intertrigo
and psoriasis.
ELEUPHRAT Lotion is indicated wherever hair impedes access to the skin
in the treatment of
corticosteroid-responsive dermatoses particularly on the scalp, chest
and underarms, etc. It is also
indicated in the treatment of seborrhoea and psoriasis of the scalp.
4.2
DOSE AND METHOD OF ADMINISTRATION
ELEUPHRAT Cream, Ointment: Apply a small amount to the affected area
twice daily. For some
patients adequate maintenance therapy may be achieved with once daily
application.
ELEUPHRAT Lotion: Apply twice daily. Part the hair with a comb, then
apply with nozzle directly
on the scalp. Squeeze bottle gently.
In most cases, 4 weeks continuous treatment should be considered the
maximum.
Children: Administration of topical corticosteroids to children should
be limited to the least amount
compatible with an effective therapeutic regimen.
4.3
CONTRAINDICATIONS
2
Hypersensitivity to betamethasone dipropionate, other corticosteroids
or any compon